相关实验视频
Updated: May 5, 2026

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
从2020年到2025年:全面审查 解码新型结构抑制剂对SARS-CoV-2的Mpro
Xin Zhang1, Yuxin Xu1, Yunzhi Jiang1
1Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 主蛋白酶 (Mpro) 抑制剂对于抗病毒发展至关重要. 本综述涵盖了2020-2025年的Mpro抑制剂策略,重点关注未来的冠状病毒威胁.
科学领域:
- 病毒学 病毒学
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
背景情况:
- 严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 在全球范围内持续存在,需要持续的抗病毒策略.
- 病毒主要蛋白酶 (Mpro) 是一种有效的向,可以抑制病毒复制.
- 了解Mpro的作用是开发有效的SARS-CoV-2治疗方法的关键.
研究的目的:
- 从2020年到2025年全面审查Mpro抑制剂的开发.
- 分析针对SARS-CoV-2的各种抑制剂类 Mpro.
- 确定下一代抗病毒药物设计的机会.
主要方法:
- 关于Mpro抑制剂研究的文献综述 (2020-2025年).
- 抑制剂的分类为类药物,小分子,天然产品和PROTACs.
- 机械,结构和技术数据的整合.
主要成果:
- 详细评估四个主要的Mpro抑制剂类别.
- 对Mpro目标的合理药物设计方面的进展进行分析.
- 识别抗病毒研究中的新兴趋势和机遇.
结论:
- 对于对抗SARS-CoV-2和未来的冠状病毒,Mpro仍然是一个关键目标.
- 多种抑制剂策略显示出下一代抗病毒药物的前景.
- 持续的研究整合机械和结构洞察力对于有效的药物开发至关重要.
更多相关视频
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
05:50Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
相关概念视频
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Subviral Agents
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Viral Protein Synthesis